Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Zogenix Inc. : Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results

05/03/2013 | 08:40am US/Eastern
Conference Call Scheduled for May 9, 2013 at 4:30 pm ET

SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the first quarter ended March 31, 2013, after the market closes on Thursday, May 9, 2013, and will hold a conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these financial results and provide a company update.

To access the live webcast please visit the Company's Investor Relations website at ir.zogenix.com, and to participate, please dial (866) 318-8616 (U.S.) or (617) 399-5135 (International); participant passcode: 65838569.

The conference call will be hosted by Chief Executive Officer Roger L. Hawley, President Stephen J. Farr, Ph.D., and Executive Vice President and Chief Financial Officer Ann Rhoads.

A replay of the conference call will be available beginning May 9, 2013 at 6:30 p.m. ET (3:30 p.m. PT) until May 16, 2013, by dialing (888) 286-8010 (U.S.) or (617) 801-6888 (International); passcode: 23471504. A replay of the webcast will also be accessible on the Investor Relations website for one month, through June 9, 2013.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX), with offices in San Diego and Emeryville, California, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL® DosePro® (sumatriptan injection) Needle-free Delivery System, was launched in January 2010 for the acute treatment of migraine and cluster headache. Zogenix's lead investigational product candidate, Zohydro™ ER (hydrocodone bitartrate), is an oral, extended-release formulation of various strengths of hydrocodone, without acetaminophen, intended for administration every 12 hours for around the clock management of moderate to severe chronic pain. In May 2012, Zogenix submitted to the FDA a New Drug Application for Zohydro ER. Zogenix's second investigational product candidate, Relday™, is a proprietary, long-acting injectable formulation of risperidone for the treatment of schizophrenia; an investigational new drug application was submitted to the FDA in May 2012. For additional information, please visit www.zogenix.com.

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com

         MEDIA:
         Caitlin Cox | The Ruth Group
         646.536.7033 | ccox@theruthgroup.com
Zogenix
distributed by
React to this article
Latest news
Date Title
<1m ago ADVANCE RESIDENCE INVESTMENT : Notice Concerning Debt Financing
<1m ago QUIZAM MEDIA : Closes $200,000 Private Placement
<1m ago ADVANCE RESIDENCE INVESTMENT : Notice Concerning The Revision of Management Performance Forecast and Dividend for the Fiscal Period Ending January 2015 (the Ninth FP)
<1m ago MOSKOVSKAYA BIRZHA : Risk Parameters for New Currencies on FX Market
<1m ago WATERCO : Uni and companies work on water project
<1m ago BAYERISCHE MOTOREN WERKE : Luxury Merc has professional touch ; DRIVELINES
<1m ago Take 5 Xmas wreaths ; CASH QUEENS
<1m ago Crude Oil Remains Vulnerable As OPEC Fans Global Supply Glut Concerns
1m ago Audi's a hy flyer
1m ago POUNDLAND : Made-up about cosmetic sales
Latest news
Advertisement
Hot News 
IMPAX ASSET MANAGEMENT : reports growth across the board
SHAFTESBURY : bolstered by West End property investment boom
RPC : UK plastics firm buys Icelandic rival for €386m
A bright new day for Monitise as new backers join
BG : *traders: nomura cuts bg group to 'reduce'
Most Read News
1d ago WHOLE FOODS MARKET : Jordan named president of Whole Foods’ Rockies division
1d ago GLENCORE : invests in Congo hydropower as solution to blackouts
1d ago SIMON PROPERTY : May Be Looking to Buy Macerich, Recent Transactions Indicate
1d ago MACERICH : 10 Must Reads for the CRE Industry Today (November 20, 2014)
1d ago NAVISTAR : New disaster-relief truck design unveiled
Most recommended articles
26m agoDJCURRENCIES : Dollar Stronger Against Yen After OPEC Decision
41m ago Poor performance catching up with active stock fund managers
42m agoDJDollar Stronger Against Yen After OPEC Decision
49m ago Poor performance catching up with active stock fund managers
59m ago FUKUSHIMA WORKERS STILL IN MURKY LABOR CONTRACTS : Tepco survey
Dynamic quotes  
ON
| OFF